OverviewSuggest Edit

NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3 inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation. In contrast, most mitral valve repair procedures are performed through a 3 to 10 inch chest incision (sternotomy) which involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on bypass.
HQMinneapolis, US


NeoChord is headquartered in
Minneapolis, United States

Location Map

Latest Updates

Employees (est.) (Oct 2019)25(+9%)

Key People/Management at NeoChord

John Seaberg

John Seaberg

Chairman and CEO
Ron M. Nelson

Ron M. Nelson

Show more

NeoChord Office Locations

NeoChord has an office in Minneapolis
Minneapolis, US (HQ)
Parkdale 2, 5402 Parkdale Dr #160
Show all (1)

NeoChord Financials and Metrics

Summary Metrics

Founding Date


NeoChord total Funding

$74.7 m

NeoChord latest funding size

$7 m

Time since last funding

6 months ago

NeoChord investors

NeoChord's latest funding round in April 2019 was reported to be $7 m. In total, NeoChord has raised $74.7 m
Show all financial metrics

NeoChord Online and Social Media Presence

Embed Graph

NeoChord Frequently Asked Questions

  • When was NeoChord founded?

    NeoChord was founded in 2007.

  • Who are NeoChord key executives?

    NeoChord's key executives are John Seaberg and Ron M. Nelson.

  • How many employees does NeoChord have?

    NeoChord has 25 employees.

  • Who are NeoChord competitors?

    Competitors of NeoChord include CardioMech, CarThera and PQ Bypass.

  • Where is NeoChord headquarters?

    NeoChord headquarters is located at Parkdale 2, 5402 Parkdale Dr #160, Minneapolis.

  • Where are NeoChord offices?

    NeoChord has an office in Minneapolis.

  • How many offices does NeoChord have?

    NeoChord has 1 office.